Indeed, there are mouthwashes on the market based on salivary enzymes including lactoferrin [41], some of them oxygenated [42], which have been used successfully in the treatment of xerostomia, demonstrating that a release model in the oral cavity as hypothesized can be easily achieved. The gene discussed is LTF; the disease is xerostomia.